These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15838360)

  • 1. Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S59-63. PubMed ID: 15838360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endothelin receptors in the brain of SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S156-9. PubMed ID: 15838268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of endothelin and its receptors in the brain of SHR-SP at malignant hypertensive stage.
    Jesmin S; Sakuma I; Togashi H; Yamaguchi T; Ueno K; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S11-5. PubMed ID: 15838256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR.
    Li Y; Lévesque LO; Anand-Srivastava MB
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1959-67. PubMed ID: 20852045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of Gqα and PLC-β1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1.
    Atef ME; Anand-Srivastava MB
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C97-106. PubMed ID: 24760983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
    Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
    Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of endothelin action normalizes altered levels of VEGF and its signaling in the brain of stroke-prone spontaneously hypertensive rat.
    Jesmin S; Maeda S; Mowa CN; Zaedi S; Togashi H; Prodhan SH; Yamaguchi T; Yoshioka M; Sakuma I; Miyauchi T; Kato N
    Eur J Pharmacol; 2007 Nov; 574(2-3):158-71. PubMed ID: 17689527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
    Cediel E; Vázquez-Cruz B; Navarro-Cid J; de las Heras N; Sanz-Rosa D; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2002 Dec; (82):S2-7. PubMed ID: 12410847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
    de Beer VJ; Sorop O; Pijnappels DA; Dekkers DH; Boomsma F; Lamers JM; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2069-77. PubMed ID: 18310517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
    Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
    Touyz RM; Fareh J; Thibault G; Schiffrin EL
    Hypertension; 1996 Nov; 28(5):797-805. PubMed ID: 8901826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats.
    Endo Y; Arima S; Yaoita H; Tsunoda K; Omata K; Ito S
    J Vasc Res; 1998; 35(6):421-7. PubMed ID: 9858867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats.
    Romero-Nava R; Rodriguez JE; Reséndiz-Albor AA; Sánchez-Muñoz F; Ruiz-Hernandéz A; Huang F; Hong E; Villafaña S
    Clin Exp Hypertens; 2016; 38(1):56-62. PubMed ID: 26268856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.